The use of the AstraZeneca vaccine to protect against COVID-19 in Spain will be widened to include people aged 66-69, the health ministry announced Thursday.
Damage to the autism-associated gene Dyrk1a, sets off a cascade of problems in developing mouse brains, resulting in abnormal growth-factor signaling, undergrowth of neurons, smaller-than-average brain […]
When scientists need to understand the effects of new infant formula ingredients on brain development, it’s rarely possible for them to carry out initial safety studies […]